Recent evidences suggest that silibinin, a commonly occurring flavonoid can inhibit the IGF-I secretions, and increase the level of IGFBP-3 and induce of apoptosis in both in vivo and in vitro model of prostate cancer [33,34]. Here, IGF1 is linked to prostate carcinoma.